Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 528, pseudogene (RNU6-528P) is a transcribed pseudogene based on the highly conserved U6 small nuclear RNA (snRNA) sequence[4][5]. U6 snRNA itself is a non-coding RNA that forms part of the spliceosome, the cellular machinery responsible for the removal of introns from pre-mRNA in eukaryotes[3]. U6-derived pseudogenes like RNU6-528P are numerous in vertebrate genomes, a possible reflection of the U6 gene’s evolutionary and functional importance[3][5]. However, these pseudogenes, including RNU6-528P, are typically non-functional, do not code for active spliceosomal RNA, and are not recognized as therapeutic targets or regulators in established drug or disease pathways[2][6]. Their functional role, if any, is not well defined, and the majority remain transcriptionally inactive or non-functional in current evidence[6]. RNU6-528P is a transcribed RNA pseudogene, unrelated to receptors, enzymes, or other canonical drug targets; there is no established functional, therapeutic, or disease relevance for this molecule.
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 528, pseudogene (RNU6-528P).